Omitted Information definition

Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] be conducted, as outlined in the Research Program in Appendix B of this Agreement. Such research shall be performed at a cost of One Hundred Eighty Five Thousand U.S. Dollars (US $185,000). Such payment shall be made to DGI on a quarterly basis. During the Research Program; (i) an exchange of information shall occur on an ad hoc basis between scientists, and (ii) at the conclusion of the Research Program, DGI shall submit a report to Novo Nordisk stating all results of the Research Program. Upon the completion of said research, the Parties shall mutually decide whether further work is necessary.
View Source
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] other Party shall notify the defaulting Party in writing of the default and allow the defaulting Party ninety (90) days from such notification to initiate reasonable steps to cure such default. Notwithstanding this section 19.2, if the defaulting Party disputes the existence, nature or extent of any default set forth above, the Parties shall use good faith efforts to resolve the dispute pursuant to Article 17. This Agreement shall continue until a final decision is reached pursuant to Article 17.
View Source
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] not limited to, place, frequency and form. The first meeting ofthe Steering Committee shall take place no later than thirty (30) days after the execution date of this Agreement.
View Source

Examples of Omitted Information in a sentence

  • LAWS Each Party hereto agrees that it shall comply with all applicable international, country and local laws, ordinances and codes in performing its obligations hereunder, including the procurement of sublicenses, permits, certificates, "Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] registrations and any other requirements necessary to comply with this Agreement.

  • Blume, President Fax: ▇▇▇-▇▇▇-▇▇▇▇ With copy to: ▇▇▇▇▇▇▇, Del Deo, Dolan, Griffinger & ▇▇▇▇▇▇▇▇▇ ▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ ▇▇▇▇▇ "Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] ▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇ Attention: ▇▇▇▇▇▇▇ ▇.

  • If any payments made by Novo Nordisk under "Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] this Agreement is subject to withholding tax, such withholding tax shall be borne by DGI and shall be deducted from the payments made by Novo Nordisk.

  • SGRE is duly represented by Mr. [Omitted Information], of legal age and German nationality, with professional domicile at Parque Tecnológico de Bizkaia, Edificio 222, 48170 ▇▇▇▇▇▇▇ (Bizkaia), Spain, and [Omitted Information], of legal age and German nationality, with professional domicile at Parque Tecnológico de Bizkaia, Edificio 222, 48170 ▇▇▇▇▇▇▇ (Bizkaia), Spain, each acting in his respective capacity as authorized representative of SGRE.

  • If such notice of objection is not delivered prior to the date specified above, the Omitted Information shall be deemed approved by Purchaser.

  • In each case except with respect to matters relating to the Company’s representations and warranties in Section 3 hereof, such Buyer agrees that the Company shall not be obligated to disclose any Omitted Information or have any liability to such Buyer with respect to any such non-disclosure.

  • Seller shall use "reasonable efforts" to correct, cure or remove at or prior to Closing any conditions or circumstances disclosed by Omitted Information of which Purchaser has timely given notice to Seller (which cure may include, among other things, the delivery of an estoppel certificate, reasonably acceptable to Purchaser, or other document or instrument at Closing), or (y) agreeing to credit the Consideration at Closing by an amount necessary to cure, correct or remove the specified condition(s).

  • If Seller is unable, at or prior to Closing, to correct, cure or remove any condition or circumstance disclosed by the Omitted Information which is not reasonably satisfactory to Purchaser, Purchaser may proceed to Closing on the applicable Property without reduction of the Consideration, or terminate this Agreement with respect to the applicable Property and there shall be no further obligations hereunder with respect to said Property.

  • In the event that MEDIMMUNE is unable to fill an order for DISTRIBUTOR, then *Omitted Information is the subject of a request for confidential treatment pursuant to Rule 24b-2 under the Securities Exchange Act of 1934 and has been filed separately with the Securities and Exchange Commission.

  • Purchaser is deemed to have objected to the Omitted Information set forth on EXHIBIT F.


More Definitions of Omitted Information

Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] Nordisk with advance copies of any papers to be filed in a patent office relating to DGI Patent Rights with sufficient time for Novo Nordisk to provide its comments to DGI before the filing of said papers.
View Source
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] more than fifty percent (50%) of the royalties due under Section 3.4. Novo Nordisk shall continue to take a credit against royalty payments until the sum of the milestone fees has been fully credited.
View Source
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *]
View Source
Omitted Information filed separately with SEC-Confidential Treatment Requested by New Brunswick Scientific Co., Inc." and indicated as [* *] B is the average sale price of the other product(s) sold separately in finished form. In the event that the average sale price of the Licensed Product can be determined but the average sale price of the other product(s) cannot be determined, Net Sales for purposes of determining royalty payments shall be calculated by multiplying the Net Sales of the Combination Products by the fraction C/(C + D) where C is the selling party's average sales price of the Licensed Product and D is the difference between the average selling price of the Combination Product and the average selling price of the Licensed Product. If the average sale price of the other product(s) can be determined but the average price of the Licensed Product cannot be determined, Net Sales for purposes of determining royalty payment shall be calculated by multiplying the Net Sales of the Combination Products by the following formula: one (1) minus C/(C + D) where C is the average selling price of the other product(s) and D is the difference between the average selling price of the Combination Products and the average selling price of the other product(s). In no event, however, shall the Net Sales of Licensed Products be less than fifty percent (50%) of the Net Sales of the Combination Products.
View Source
Omitted Information shall have the meaning as defined in Section 1.35.
View Source

Related to Omitted Information

  • Requested Information has the meaning set forth in Section 4.3(a).

  • Exempted Information means any Information that is designated as falling or potentially falling within the FOIA Exemptions or the EIR Exceptions; Expert means:

  • Licensed Information means any information concerning the Licensed Program, which is owned by the Licensor and is licensed to the Licensee together with the Licensed Program. Licensed Information includes such information as input form, user manual, interface format and input/output format and is delivered to and used by the Licensee as confidential information or proprietary property of the Licensor.

  • Generated Information means information produced in the performance of this CRADA.

  • Disclosed Information means the information disclosed by a Party for the purpose of settlement, negotiation, Mediation or Arbitration;